Skip to search formSkip to main contentSkip to account menu

ABT 702

Known as: 4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido(2,3-d)pyrimidine, ABT-702 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MorpholinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Role of Adenosine Receptor A2A in Traumatic Optic Neuropathies (Addendum)
Abstract : This report summarizes the research progress and outcome of Traumatic optic neuropathy (TON). The report describes… 
2016
2016
The Effect of Endogenous Adenosine on Neuronal Activity in Rats: An FDG PET Study
2–18F‐fluorodeoxy‐D‐glucose (FDG) is a glucose analog that is taken up by cells and phosphorylated. The amount of FDG accumulated… 
2015
2015
An adenosine kinase inhibitor, ABT-702, inhibits spinal nociceptive transmission by adenosine release via equilibrative nucleoside transporters in rat
2002
2002
Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)